Wells Fargo’s Ingevity NGVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.29M | Sell |
32,106
-26,575
| -45% | -$1.82M | ﹤0.01% | 3175 |
|
|
2025
Q4 | $3.47M | Buy |
58,681
+16,950
| +41% | +$920K | ﹤0.01% | 3002 |
|
|
2025
Q3 | $2.3M | Buy |
41,731
+3,135
| +8% | +$163K | ﹤0.01% | 3217 |
|
|
2025
Q2 | $1.66M | Buy |
38,596
+1,373
| +4% | +$53K | ﹤0.01% | 3357 |
|
|
2025
Q1 | $1.47M | Buy |
37,223
+168
| +0.5% | +$7.43K | ﹤0.01% | 3401 |
|
|
2024
Q4 | $1.51M | Buy |
37,055
+11,742
| +46% | +$489K | ﹤0.01% | 3407 |
|
|
2024
Q3 | $987K | Sell |
25,313
-26,580
| -51% | -$1.06M | ﹤0.01% | 3554 |
|
|
2024
Q2 | $2.27M | Sell |
51,893
-8,956
| -15% | -$433K | ﹤0.01% | 2885 |
|
|
2024
Q1 | $2.9M | Buy |
60,849
+8,224
| +16% | +$370K | ﹤0.01% | 2674 |
|
|
2023
Q4 | $2.48M | Sell |
52,625
-10,181
| -16% | -$423K | ﹤0.01% | 2733 |
|
|
2023
Q3 | $2.99M | Sell |
62,806
-11,444
| -15% | -$625K | ﹤0.01% | 2481 |
|
|
2023
Q2 | $4.32M | Buy |
74,250
+9,330
| +14% | +$560K | ﹤0.01% | 2268 |
|
|
2023
Q1 | $4.64M | Buy |
64,920
+5,296
| +9% | +$420K | ﹤0.01% | 2175 |
|
|
2022
Q4 | $4.2M | Sell |
59,624
-525
| -0.9% | -$37K | ﹤0.01% | 2215 |
|
|
2022
Q3 | $3.65M | Sell |
60,149
-1,161
| -2% | -$77.9K | ﹤0.01% | 2232 |
|
|
2022
Q2 | $3.87M | Sell |
61,310
-25,439
| -29% | -$1.66M | ﹤0.01% | 2282 |
|
|
2022
Q1 | $5.56M | Sell |
86,749
-5,417
| -6% | -$362K | ﹤0.01% | 2368 |
|
|
2021
Q4 | $6.61M | Sell |
92,166
-69,199
| -43% | -$5.26M | ﹤0.01% | 2277 |
|
|
2021
Q3 | $11.5M | Sell |
161,365
-2,293
| -1% | -$181K | ﹤0.01% | 2079 |
|
|
2021
Q2 | $13.3M | Sell |
163,658
-13,356
| -8% | -$1.07M | ﹤0.01% | 1993 |
|
|
2021
Q1 | $13.4M | Sell |
177,014
-106,923
| -38% | -$7.78M | ﹤0.01% | 1969 |
|
|
2020
Q4 | $21.5M | Sell |
283,937
-310,818
| -52% | -$20.2M | 0.01% | 1507 |
|
|
2020
Q3 | $29.4M | Sell |
594,755
-240,476
| -29% | -$13.6M | 0.01% | 1163 |
|
|
2020
Q2 | $43.9M | Buy |
835,231
+571,334
| +216% | +$27.1M | 0.01% | 913 |
|
|
2020
Q1 | $9.29M | Sell |
263,897
-692,424
| -72% | -$40.4M | ﹤0.01% | 1727 |
|
|
2019
Q4 | $83.6M | Sell |
956,321
-114,320
| -11% | -$10M | 0.02% | 679 |
|
|
2019
Q3 | $90.8M | Sell |
1,070,641
-2,853
| -0.3% | -$254K | 0.03% | 607 |
|
|
2019
Q2 | $113M | Buy |
1,073,494
+28,942
| +3% | +$2.91M | 0.03% | 525 |
|
|
2019
Q1 | $110M | Sell |
1,044,552
-83,699
| -7% | -$8.41M | 0.03% | 510 |
|
|
2018
Q4 | $94.4M | Buy |
1,128,251
+351,352
| +45% | +$31.8M | 0.03% | 530 |
|
|
2018
Q3 | $79.2M | Buy |
776,899
+683,611
| +733% | +$66M | 0.02% | 690 |
|
|
2018
Q2 | $7.54M | Sell |
93,288
-29,003
| -24% | -$2.3M | ﹤0.01% | 2299 |
|
|
2018
Q1 | $9.01M | Sell |
122,291
-109,335
| -47% | -$8.18M | ﹤0.01% | 2108 |
|
|
2017
Q4 | $16.3M | Sell |
231,626
-129,977
| -36% | -$9.38M | ﹤0.01% | 1608 |
|
|
2017
Q3 | $22.6M | Buy |
361,603
+58,989
| +19% | +$3.49M | 0.01% | 1332 |
|
|
2017
Q2 | $17.4M | Buy |
302,614
+230,558
| +320% | +$13.6M | 0.01% | 1482 |
|
|
2017
Q1 | $4.38M | Buy |
72,056
+37,259
| +107% | +$2.11M | ﹤0.01% | 2535 |
|
|
2016
Q4 | $1.91M | Buy |
34,797
+13,840
| +66% | +$664K | ﹤0.01% | 3198 |
|
|
2016
Q3 | $966K | Buy |
20,957
+421
| +2% | +$17.8K | ﹤0.01% | 3516 |
|
|
2016
Q2 | $699K | Buy |
+20,536
| New | +$641K | ﹤0.01% | 3713 |
|
Other funds holding NGVT
VPM
VCM
SBH
SCM
Wells Fargo's NGVT Position: Q1 2026 in Review
Wells Fargo reduced its Ingevity (NGVT) stake by 45% in Q1 2026, selling an estimated $1.82M and leaving 32,106 shares worth $2.29M. The position accounts for ﹤0.01% of the portfolio, ranked #3175.
Wells Fargo first reported a position in NGVT in Q2 2016 and has held it in 40 quarters since. The position peaked at $113M in Q2 2019. 307 funds tracked by Wall St. Rank hold NGVT as of Q1 2026.
- Wells Fargo held 32,106 shares of Ingevity worth $2.29M as of Q1 2026.
- Wells Fargo sold 26,575 Ingevity shares in Q1 2026, an estimated $1.82M.
- Ingevity made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #3175 holding.
- Wells Fargo first reported a position in Ingevity in Q2 2016 and has held it in 40 quarters since.
- Wells Fargo's Ingevity position peaked at $113M in Q2 2019.
- 307 funds tracked by Wall St. Rank held Ingevity as of Q1 2026.
Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.